G.Barekat Pharm (XTEH:BRKT1) YoY EBITDA Growth : 24.74% (As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. G.Barekat Pharm's YoY EBITDA Growth for the quarter that ended in Mar. 2017 was 24.74%.

G.Barekat Pharm's EBITDA per Share for the six months ended in Mar. 2017 was IRR1,084.80.

G.Barekat Pharm YoY EBITDA Growth Historical Data

The historical data trend for G.Barekat Pharm's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm YoY EBITDA Growth Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

YoY EBITDA Growth

24.74

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
YoY EBITDA Growth	-	24.74

G.Barekat Pharm YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

G.Barekat Pharm's YoY EBITDA Growth for the fiscal year that ended in Mar. 2017 is calculated as:

	YoY EBITDA Growth (A: Mar. 2017 )
=	(EBITDA per Share (A: Mar. 2017 )	-	EBITDA per Share (A: Mar. 2016 ))	/	\| EBITDA per Share (A: Mar. 2016 ) \|
=	(1084.799	-	869.654)	/	\| 869.654 \|
=	24.74 %

G.Barekat Pharm's YoY EBITDA Growth for the quarter that ended in Mar. 2017 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2017 )
=	(EBITDA per Share (Q: Mar. 2017 )	-	EBITDA per Share (Q: Mar. 2016 ))	/	\| EBITDA per Share (Q: Mar. 2016 ) \|
=	(1084.799	-	869.654)	/	\| 869.654 \|
=	24.74 %

G.Barekat Pharm YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines